Trials / Conditions / Metastatic NSCLC - Non-Small Cell Lung Cancer

Metastatic NSCLC - Non-Small Cell Lung Cancer

8 registered clinical trials studyying Metastatic NSCLC - Non-Small Cell Lung Cancer — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) NCT07149649	Swiss Cancer Institute	Phase 2 / Phase 3
Recruiting	Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older NCT07020065	Swiss Cancer Institute	Phase 2
Not Yet Recruiting	ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) NCT06813664	University Health Network, Toronto	Phase 2
Recruiting	Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertio NCT07392658	Fondazione Ricerca Traslazionale	Phase 2
Recruiting	Large Granular Lymphocytes in mNSCLC Treated With Nivolumab NCT07363811	Necmettin Erbakan University	—
Not Yet Recruiting	A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) NCT05859217	Jun Zhang, MD, PhD	Phase 2
Recruiting	Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform NCT05478538	Elephas	—
Active Not Recruiting	Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lun NCT05403385	iTeos Therapeutics	Phase 2